US biotech firm Moderna said Sunday that American officials have delayed approving its COVID-19 vaccine for teenagers to allow more time to better assess the potential risk of developing myocarditis,... from NDTV News - World-news https://ift.tt/3CzxYlY
Latest Studio: Your go-to destination for breaking news, in-depth analysis, and insightful updates from around the world. We cover a wide range of topics, from global events and politics to culture and technology, ensuring you stay informed and engaged with the latest developments. Join us to explore stories that matter and insights that inspire.